SNDX – syndax pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target raised by analysts at Mizuho from $410.00 to $600.00. They now have an "outperform" rating on the stock.
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory [Yahoo! Finance]
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Form 4 Syndax Pharmaceuticals For: Feb 04 Filed by: Metzger Michael A
Form 4 Syndax Pharmaceuticals For: Feb 04 Filed by: Goldan Keith A.
Form 4 Syndax Pharmaceuticals For: Feb 04 Filed by: Jarrett Jennifer
Form 4 Syndax Pharmaceuticals For: Feb 04 Filed by: Huber Martin H. Jr.
Form 4 Syndax Pharmaceuticals For: Feb 04 Filed by: Botwood Nicholas A.J.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.